Physician

Alan M Kramer, MD

According to 2025 Medicare claims, Alan Kramer, MD (NPI: 1356357347) practices hematology/oncology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Francisco, CA. This provider's primary affiliated billing organization is SAN FRANCISCO ONCOLOGY ASSOCIATES MEDICAL GROUP INC (NPI: 1457385379; TIN: 943255519) and primary practice location at 94115-2378. Kramer is affiliated with the APA ACO Inc. (ACO ID: D0215), participating under the REACH model.

Kramer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 191 traditional Medicare patients, billed 45,808 HCPCS/CPT codes, and received $960,381 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 829 prescription claims across 123 beneficiaries totaling $2,692,558 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 12 claims. Open Payments data shows 86 records totaling $2,537. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $747,124 and ending at $960,381. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $597,331 to $2,692,558. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.